News

The collaboration strengthens the capabilities of Tower’s advanced passive temperature-controlled containers.

The acquisition initiates a long-term agreement with Beacon Therapeutics, highlighted by clinical and commercial AAV production.

The latest news for pharma industry insiders.

The program recognizes organizations that prioritize the highest standards of care when it comes to the handling and transportation of goods in the healthcare space.

The new products offer more temperature control and sustainability benefits.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value & Access Advisor, Schoonveld Advisory, offers his thoughts on lower drug prices in the US and provides a sneak peak into future PC features.

The latest news for pharma industry insiders.

The program intends to address pharmacy deserts, which are predominantly found in underserved communities.

The first commercial shipments are scheduled for mid-April.

The latest news for pharma industry insiders.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory and author of The Price of Global Health, explains why pharmaceutical products tend to cost more in the US than the rest of the world.

Although AI has simplified various market access processes, this technology does also present its share of barriers, so what can be done to find a happy medium?

Year-on-year growth in demand is strong, according to the IATA.

The latest news for pharma industry insiders.

Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.

Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics.

The two company’s will provide consumers with a platform where they can compare drug prices.

The latest news for pharma industry insiders.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, explores the two major strategies big pharma companies are employing amid current macro challenges and efforts to offset looming patent losses to blockbuster brands.

The latest news for pharma industry insiders.

Patients should not have to wait to access the medication they need.

Cross-sectional study explores the impact of this monumental Supreme Court ruling.

The latest news for pharma industry insiders.

Qualitative study breaks down challenges and priorities of the Medicare Shared Savings Program, as noted by affordable care organizations.

Fighting for patient affordability doesn’t necessarily require a scapegoat.

Exploring how current and future legislation may impact the role of pharmacy benefit managers (PBMs).

A breakdown of the issues surrounding retail pharmacy—and what can be done to address these difficulties in a timely manner.

In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s life sciences division, discusses the hottest therapeutic settings for dealmaking activity at the moment—and one platform approach in particular poised to be at the center of future M&A and licensing pursuits.

The latest news for pharma industry insiders.

Five of the company’s vaccines are currently in Phase III.